Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

EAU 2024: Bladder cancer latest

Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in 1L ES-SCLC

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Multiple myeloma in a resource constrained setting

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results

Updates on lung cancer from WCLC and ESMO 2023

Lenvatinib and pembrolizumab show promising efficacy in first-line treatment of aRCC

Personalised systemic treatment in advanced prostate cancer

Colorectal cancer risk factors in Nigeria